Related references
Note: Only part of the references are listed.The Risk of Urinary Tract Infection after Flexible Cystoscopy in Patients with Bladder Tumor Who Did Not Receive Prophylactic Antibiotics
Harry W. Herr
JOURNAL OF UROLOGY (2015)
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort
Laura-Maria Krabbe et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Evaluating Hematuria: Impact of Guideline Adherence on Urologic Cancer Diagnosis
Atul B. Shinagare et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Variation in the Intensity of Hematuria Evaluation: A Target for Primary Care Quality Improvement
David F. Friedlander et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK
A. R. Brentnall et al.
BRITISH JOURNAL OF CANCER (2014)
Non-visible versus visible haematuria and bladder cancer risk: a study of electronic records in primary care
Sarah J. Price et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2014)
The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer
Martin Filipits et al.
CLINICAL CANCER RESEARCH (2014)
The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
Robert S. Svatek et al.
EUROPEAN UROLOGY (2014)
Prospective External Validation of a Bladder Cancer Detection Model
Yair Lotan et al.
JOURNAL OF UROLOGY (2014)
The Health Economics of Bladder Cancer: An Updated Review of the Published Literature
Christina Yeung et al.
PHARMACOECONOMICS (2014)
What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up
Anna Buteau et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Gene-based urinary biomarkers for bladder cancer: An unfulfilled promise?
Nikhil Sapre et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Stratifying Patients with Haematuria into High or Low Risk Groups for Bladder Cancer: a Novel Clinical Scoring System
Guan Hee Tan et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2-breast cancer patients
P. Dubsky et al.
BRITISH JOURNAL OF CANCER (2013)
Combination of Molecular Alterations and Smoking Intensity Predicts Bladder Cancer Outcome A Report From the Los Angeles Cancer Surveillance Program
Anirban P. Mitra et al.
CANCER (2013)
Stratifying Risk of Urinary Tract Malignant Tumors in Patients With Asymptomatic Microscopic Hematuria
Ronald K. Loo et al.
MAYO CLINIC PROCEEDINGS (2013)
Optimal Triage Test Characteristics to Improve the Cost-Effectiveness of the Xpert MTB/RIF Assay for TB Diagnosis: A Decision Analysis
Anna H. van't Hoog et al.
PLOS ONE (2013)
Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic
Christopher G. T. Blick et al.
BJU INTERNATIONAL (2012)
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria
Funso Abogunrin et al.
CANCER (2012)
A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria
Paul O'Sullivan et al.
JOURNAL OF UROLOGY (2012)
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
Rodney Davis et al.
JOURNAL OF UROLOGY (2012)
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer
Eugene K. Cha et al.
WORLD JOURNAL OF UROLOGY (2012)
Comparison of virtual cystoscopy and ultrasonography for bladder cancer detection: A meta-analysis
Xinhua Qu et al.
EUROPEAN JOURNAL OF RADIOLOGY (2011)
Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis
Graham Mowatt et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2011)
RE-DESIGN OF A HAEMATURIA CLINIC: ASSESSMENT OF 2436 HAEMATURIA PATIENTS
Peter Davidson
JOURNAL OF UROLOGY (2011)
Evaluation and Management of Hematuria
Masahito Jimbo
PRIMARY CARE (2010)
Urine Cytology in the Evaluation of Urological Malignancy Revisited: Is It Still Necessary?
Opeyemi Adegboyega Falebita et al.
UROLOGIA INTERNATIONALIS (2010)
Utility of Urine Cytology in the Workup of Asymptomatic Microscopic Hematuria in Low-risk Patients
Andrew H. Feifer et al.
UROLOGY (2010)
Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection
Yair Lotan et al.
BJU INTERNATIONAL (2009)
Assessment and management of non-visible haematuria in primary care
John D. Kelly et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Early results of bladder-cancer screening in a high-risk population of heavy smokers
Hannes Steiner et al.
BJU INTERNATIONAL (2008)
How to evaluate dipstick hematuria What to do before you refer
Pravin Kumar et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2008)
Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder
Andrew Holyoake et al.
CLINICAL CANCER RESEARCH (2008)
Is routine urine cytology useful in the haematuria clinic?
S. Viswanath et al.
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (2008)
Detection of bladder cancer using a point-of-care proteomic assay
HB Grossman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
A breast cancer prediction model incorporating familial and personal risk factors
J Tyrer et al.
STATISTICS IN MEDICINE (2004)
The community-based morbidity of flexible cystoscopy
DM Burke et al.
BJU INTERNATIONAL (2002)
Microscopic hematuria as a screening marker for urinary tract malignancies
K Sugimura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2001)
A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice
MH Khadra et al.
JOURNAL OF UROLOGY (2000)